Hospital Universitario De Getafe

At Hospital Universitario De Getafe, the Nephrology team is leading studies focused on chronic kidney disease and related renal disorders. The research is aimed at improving treatment effectiveness, slowing disease progression, and reducing kidney-related complications.

• Chronic kidney disease and chronic renal disease management
• IgA nephropathy and proteinuria reduction
• Testing new approaches to protect kidney function and improve long-term outcomes

This portfolio also includes studies linking kidney health with broader cardiovascular risk, reflecting the strong overlap between renal and vascular care.

The site is actively involved in research on cardiovascular diseases, especially conditions that affect circulation and clot formation. These trials are designed to evaluate better strategies for prevention and treatment in patients at risk of serious events.

• Acute pulmonary embolism and clot-related complications
• Anemia in patients with lower-limb ischemia
• Assessing therapies that may reduce cardiovascular events and improve recovery

This work supports more personalized care for people with complex vascular disease, including patients treated at Hospital Universitario De Getafe.

Research in respiratory tract diseases and critical illness is an important part of the trial activity at this hospital. The studies focus on improving outcomes for patients with severe breathing problems and intensive care needs.

• Acute respiratory distress syndrome linked to infections
• Pneumonia and severe community-acquired lung infection
• Evaluating treatments that may improve breathing support and survival

There is also interest in optimizing care for critically ill patients, including approaches that may reduce time on mechanical ventilation.

The research program includes studies in nervous system diseases and mental disorders, with a focus on symptoms that affect cognition, behavior, and daily functioning. These trials are intended to improve symptom control and support better quality of life.

• Multiple sclerosis treatment and relapse prevention
• Schizophrenia and related cognitive impairment
• Alzheimer’s disease with psychosis or agitation

The site’s work in this area explores both new therapies and longer-term safety, reflecting a broad commitment to neurological and psychiatric care.

Clinical trials at this center also address bacterial infections, virus diseases, and prevention through vaccines. The main goal is to improve protection against infection and test treatments for people living with chronic viral disease.

• HIV infection treatment
• Community-acquired pneumonia prevention
• Evaluating vaccine effectiveness and antiviral therapy options

This research supports both treatment innovation and public health protection in the Getafe clinical trial environment.

The hospital is involved in studies across digestive system diseases, nutritional and metabolic diseases, and immune system diseases. These trials aim to improve diagnosis, reduce complications, and test therapies for chronic inflammatory conditions.

• Diverticular disease and treatment without antibiotics
• Lactose intolerance diagnosis in children
• Rheumatoid arthritis, vitiligo, and other immune-related disorders

Overall, the research reflects a wide-ranging effort to refine care for patients with common and complex inflammatory diseases.

Additional studies at Hospital Universitario De Getafe cover musculoskeletal diseases, hemic and lymphatic diseases, and obstetric conditions. These trials are designed to improve safety and effectiveness in areas where treatment decisions can strongly affect patient outcomes.

• Osteogenesis imperfecta follow-up and safety monitoring
• Preeclampsia prevention in pregnancy
• Venous thromboembolism risk related to inflammatory treatment

This part of the portfolio highlights the site’s broad clinical research reach beyond nephrology, with studies spanning bone health, maternal care, and blood-clotting risk.